Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer

10.1186/s13046-015-0243-5

Saved in:

Bibliographic Details
Main Authors:	Huynh, H, Ong, R, Zopf, D
Other Authors:	MEDICINE
Format:	Article
Published:	2020
Subjects:	regorafenib angiogenesis inhibitor antineoplastic agent carbanilamide derivative protein kinase inhibitor pyridine derivative angiogenesis animal experiment animal model animal tissue antineoplastic activity apoptosis Article cancer inhibition cell proliferation controlled study drug efficacy drug tolerability human in vivo study male mouse nonhuman priority journal signal transduction stomach cancer treatment response tumor volume animal disease model dose response drug effects drug screening Neovascularization, Pathologic pathology Stomach Neoplasms tumor cell line Angiogenesis Inhibitors Animals Antineoplastic Agents Apoptosis Cell Line, Tumor Cell Proliferation Disease Models, Animal Dose-Response Relationship, Drug Humans Mice Phenylurea Compounds Protein Kinase Inhibitors Pyridines Tumor Burden Xenograft Model Antitumor Assays
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180879
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-180879
record_format	dspace
spelling	sg-nus-scholar.10635-1808792024-04-18T03:05:56Z Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer Huynh, H Ong, R Zopf, D MEDICINE regorafenib angiogenesis inhibitor antineoplastic agent carbanilamide derivative protein kinase inhibitor pyridine derivative regorafenib angiogenesis animal experiment animal model animal tissue antineoplastic activity apoptosis Article cancer inhibition cell proliferation controlled study drug efficacy drug tolerability human in vivo study male mouse nonhuman priority journal signal transduction stomach cancer treatment response tumor volume animal disease model dose response drug effects drug screening Neovascularization, Pathologic pathology Stomach Neoplasms tumor cell line Angiogenesis Inhibitors Animals Antineoplastic Agents Apoptosis Cell Line, Tumor Cell Proliferation Disease Models, Animal Dose-Response Relationship, Drug Humans Mice Neovascularization, Pathologic Phenylurea Compounds Protein Kinase Inhibitors Pyridines Stomach Neoplasms Tumor Burden Xenograft Model Antitumor Assays 10.1186/s13046-015-0243-5 Journal of Experimental and Clinical Cancer Research 34 1 132 2020-10-27T05:35:24Z 2020-10-27T05:35:24Z 2015 Article Huynh, H, Ong, R, Zopf, D (2015). Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer. Journal of Experimental and Clinical Cancer Research 34 (1) : 132. ScholarBank@NUS Repository. https://doi.org/10.1186/s13046-015-0243-5 17569966 https://scholarbank.nus.edu.sg/handle/10635/180879 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	regorafenib angiogenesis inhibitor antineoplastic agent carbanilamide derivative protein kinase inhibitor pyridine derivative regorafenib angiogenesis animal experiment animal model animal tissue antineoplastic activity apoptosis Article cancer inhibition cell proliferation controlled study drug efficacy drug tolerability human in vivo study male mouse nonhuman priority journal signal transduction stomach cancer treatment response tumor volume animal disease model dose response drug effects drug screening Neovascularization, Pathologic pathology Stomach Neoplasms tumor cell line Angiogenesis Inhibitors Animals Antineoplastic Agents Apoptosis Cell Line, Tumor Cell Proliferation Disease Models, Animal Dose-Response Relationship, Drug Humans Mice Neovascularization, Pathologic Phenylurea Compounds Protein Kinase Inhibitors Pyridines Stomach Neoplasms Tumor Burden Xenograft Model Antitumor Assays
spellingShingle	regorafenib angiogenesis inhibitor antineoplastic agent carbanilamide derivative protein kinase inhibitor pyridine derivative regorafenib angiogenesis animal experiment animal model animal tissue antineoplastic activity apoptosis Article cancer inhibition cell proliferation controlled study drug efficacy drug tolerability human in vivo study male mouse nonhuman priority journal signal transduction stomach cancer treatment response tumor volume animal disease model dose response drug effects drug screening Neovascularization, Pathologic pathology Stomach Neoplasms tumor cell line Angiogenesis Inhibitors Animals Antineoplastic Agents Apoptosis Cell Line, Tumor Cell Proliferation Disease Models, Animal Dose-Response Relationship, Drug Humans Mice Neovascularization, Pathologic Phenylurea Compounds Protein Kinase Inhibitors Pyridines Stomach Neoplasms Tumor Burden Xenograft Model Antitumor Assays Huynh, H Ong, R Zopf, D Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
description	10.1186/s13046-015-0243-5
author2	MEDICINE
author_facet	MEDICINE Huynh, H Ong, R Zopf, D
format	Article
author	Huynh, H Ong, R Zopf, D
author_sort	Huynh, H
title	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
title_short	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
title_full	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
title_fullStr	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
title_full_unstemmed	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
title_sort	antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/180879
_version_	1800914613712191488

Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer

Similar Items